Clinical Trials Browser

Phase 2 × Interventional × GDC-0084 × Clear all

NCT03765983 2026-01-22

GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases

Phase 2 Terminated

Breast Neoplasms

NCT05009992 2025-12-17

PNOC022

Phase 2 Recruiting

Diffuse Intrinsic Pontine Glioma

NCT03522298 2025-03-24

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Phase 2 Completed

30 enrolled 27 charts

Glioblastoma